Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Dense Cisplatin and Docetaxel in Locally Advanced NSCLC
NCT02157116Phase 2Terminated
- Sponsor
- Duke University
- Start
- May 2006
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, docetaxel in non-small cell lung cancer (NSCLC), sponsored by Duke University. Started May 2006; status: terminated.
02
Drugs
cisplatindocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02157116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157116.